Clinical Guideline for the Use of Biodegradable Rectal Spacers During Radiotherapy for Prostate Cancer
Authors:
- Hyun Ho HanHHHyun Ho Han
- Jong Kyou KwonJKJong Kyou Kwon
- Do Kyung KimDKDo Kyung Kim
- Jin Hyung JeonJJJin Hyung Jeon
- Chan Woo WeeCWChan Woo Wee
- Jae Ho ChoJCJae Ho Cho
- Ji Hee JungJJJi Hee Jung
- A Young YooAYA Young Yoo
- Jae Young JoungJJJae Young Joung
- Gee Hyun SongGSGee Hyun Song
- Seung Ju LeeSLSeung Ju Lee
- Won ParkWPWon Park
Open Access
- 31 March 2026
- journal article
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 24 (1) , 3-12
Abstract
Purpose: Radiotherapy (RT) remains a cornerstone of curative treatment for localized and locally advanced prostate cancer. However, dose escalation to improve tumor control is often constrained by the proximity of the rectum, which increases the risk of gastrointestinal (GI) and genitourinary toxicities. Biodegradable rectal spacers inserted between the prostate and rectum have emerged as an effective approach to reduce rectal radiation exposure. This guideline provides evidence-based recommendations on indications, contraindications, procedural standards, and clinical management for biodegradable rectal spacer insertion during prostate cancer RT.Materials and Methods: This guideline was developed by a multidisciplinary expert panel through a systematic review of the literature, analysis of international guidelines (National Comprehensive Cancer Network, European Association of Urology, American Society for Radiation Oncology), and expert consensus among radiation oncologists, radiologists, and urologists with clinical experience in spacer insertion. The strength of each recommendation and the level of evidence were classified according to the modified GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) system.Results: Spacer insertion is conditionally recommended (Grade C, Level I) for patients receiving definitive external-beam RT without rectal invasion. It reduces the high-dose rectal irradiation volume (V70–75) by >50%, decreases acute GI toxicity, and helps maintain bowel-related quality of life. However, the benefit for late severe toxicity (grade 2 or higher) remains debated in recent meta-analyses. Contraindications include rectal invasion, anatomical inaccessibility, infection, and material hypersensitivity. Procedures should be performed under local anesthesia in a sterile environment by trained physicians. Short-course antibiotics and simulator-based training, including completion of multiple supervised cases, are advised.Conclusion: Biodegradable rectal spacer insertion is clinically validated and effective in reducing acute rectal toxicity. Although pivotal trials demonstrated a favorable procedural safety profile, real-world postmarket data include reports of rare but severe procedural complications. This guideline provides standardized recommendations tailored to Korean clinical practice while remaining consistent with international standards, emphasizing the importance of operator training and careful patient selection.Keywords
Funding Information
- Ministry of Health and Welfare (RS-2025-02263660)
This publication has 54 references indexed in Scilit:
- American Brachytherapy Society (ABS) rectoprostatic gel spacer consensus statementBrachytherapy, 2025
- Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysisWorld Journal of Urology, 2025
- Hydrogel spacer infection during prostate cancer radiotherapy: a case report of successful abscess management through radical prostatectomyInternational Cancer Conference Journal, 2025
- SpaceOAR hydrogel complications in prostate cancer radiotherapy: a pictorial reviewAbdominal Radiology, 2025
- Bowel Disorder Incidence and Rectal Spacer Use in Patients With Prostate Cancer Undergoing RadiotherapyJAMA Network Open, 2025
- Anaphylactic shock during SpaceOAR Vue hydrogel procedureUrology Case Reports, 2024
- Depth of Hydrogel Spacer Rectal Wall Infiltration Was Not Associated With Rectal Toxicity: Results From a Randomized Prospective TrialAdvances in Radiation Oncology, 2024
- Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation TherapyJAMA Oncology, 2023
- Association of the Placement of a Perirectal Hydrogel Spacer With the Clinical Outcomes of Men Receiving Radiotherapy for Prostate CancerJAMA Network Open, 2020
- Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015